Demystifying CINV control in the complex aging patient: assessing the complexities of the aging oncology patient.
Oncology nurses play a vital role in the management of chemotherapy-induced nausea and vomiting (CINV). Serotonin-receptor antagonists, neurokinin 1 antagonists, and steroids can control nausea and vomiting associated with cancer chemotherapy, improving patients' abilities to tolerate and complete the full course of cancer treatment. Safe and effective management of CINV in older patients involves special considerations, including comorbidities, potential for drug-drug interactions and toxicities, physiologic changes related to aging, and concomitant use of complementary and alternative therapies. In this session, a multidisciplinary group of oncology specialists discussed the nursing considerations related to conventional and complementary management of CINV in this patient population.
D000367:Age Factors; D000368:Aged; D000375:Aging / Q000187:drug effects / Q000502:physiology; D000932:Antiemetics / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D015897:Comorbidity; D016903:Drug Monitoring / Q000451:nursing; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000175:diagnosis / Q000517:prevention & control; D064729:Neurokinin-1 Receptor Antagonists; D009730:Nursing Assessment / Q000379:methods*; D009859:Oncology Nursing / Q000379:methods; D010348:Patient Care Team; D018579:Patient Selection; D012307:Risk Factors; D012449:Safety; D012702:Serotonin Antagonists / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use; D014839:Vomiting / Q000139:chemically induced / Q000175:diagnosis / Q000517:prevention & control
D000932:Antiemetics; D000970:Antineoplastic Agents; D064729:Neurokinin-1 Receptor Antagonists; D012702:Serotonin Antagonists; D013256:Steroids